A carregar...
Pulmonary eosinophilia associated to treatment with natalizumab
Natalizumab (Tysabri(®)) is a leukocytes chemotaxis inhibitor that decreases the leukocytes passage through the hematoencephalic barrier and it is currently used in relapsing-remitting forms of multiple sclerosis (MS). We present a patient with allergic rhinoconjunctivitis diagnosed with MS who star...
Na minha lista:
| Publicado no: | Ann Thorac Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4966227/ https://ncbi.nlm.nih.gov/pubmed/27512514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1817-1737.185762 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|